{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T15:23:14Z","timestamp":1775143394256,"version":"3.50.1"},"reference-count":27,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2014,12,31]],"date-time":"2014-12-31T00:00:00Z","timestamp":1419984000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Surgical Oncology"],"published-print":{"date-parts":[[2015,3]]},"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Peritoneal surface malignancy is increasingly treated with cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC). This is associated with potentially high morbidity. We analyzed the incidence of delayed major complications following CRS plus HIPEC.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Delayed events were chosen as those which occurred after discharge from the hospital following CRS plus HIPEC and prior to 90 days. Major complications included any adverse event requiring intervention or intensive care unit admission.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>One hundred thirty six patients underwent 140 procedures. Eight patients (5.7%) developed delayed major complications. Complications were pancreatic pseudocyst\/pancreatitis (n\u2009=\u20093), abdominal wall dehiscence (n\u2009=\u20092), gastric perforation (n\u2009=\u20091), and ureteral stricture with associated hydronephrosis (n\u2009=\u20092).<\/jats:p><jats:p>All of the patients had undergone multivisceral resections. Seven patients achieved complete cytoreduction (cc\u2009\u2264\u20091). Mean peritoneal carcinomatosis index (PCI) was 15.25\u2009\u00b1\u20095.33 (6\u201322). Standard of care was met for the management of all the complications and all patients recovered following intervention without any further morbidity or mortality.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>There is a lack of report of the delayed major complications in patients undergoing CRS plus HIPEC in the literature. Awareness should be raised among health care providers regarding possible occurrence of such late complications given that many patients undergo CRS plus HIPEC remotely from their localities. <jats:italic>J. Surg. Oncol. 2015 111:324\u2013327<\/jats:italic>. \u00a9 2014 Wiley Periodicals, Inc.<\/jats:p><\/jats:sec>","DOI":"10.1002\/jso.23834","type":"journal-article","created":{"date-parts":[[2014,12,31]],"date-time":"2014-12-31T15:46:01Z","timestamp":1420040761000},"page":"324-327","source":"Crossref","is-referenced-by-count":13,"title":["Delayed presentation of major complications in patients undergoing cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy following hospital discharge"],"prefix":"10.1002","volume":"111","author":[{"given":"Shanel B.","family":"Bhagwandin","sequence":"first","affiliation":[{"name":"Department of Surgery Division of Surgical Oncology University of Illinois at Chicago Medical Center Chicago Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samer","family":"Naffouje","sequence":"additional","affiliation":[{"name":"Department of Surgery Division of Surgical Oncology University of Illinois at Chicago Medical Center Chicago Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Salti","sequence":"additional","affiliation":[{"name":"Department of Surgery Division of Surgical Oncology University of Illinois at Chicago Medical Center Chicago Illinois"},{"name":"Department of Surgical Oncology Edward Hospital Naperville Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,12,31]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1245\/ASO.2003.01.018"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-006-0038-0"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.23.9285"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-007-9348-1"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamcollsurg.2006.12.048"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-013-2439-1"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-012-2240-7"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.sla.0000133083.54934.ae"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(20000115)88:2<358::AID-CNCR16>3.0.CO;2-O"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e3181a45d86"},{"key":"e_1_2_6_12_1","unstructured":"Kuijpers AMJ B Mirck AGJ Aalbers et al.: Cytoreduction and HIPEC in the Netherlands: Nationwide long\u2010term outcome following the Dutch protocol. Ann Surg Oncol DOI 10.1245\/s10434\u2010013\u20103145\u20109."},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2013.3640"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.19.7160"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.25356"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-012-0397-5"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21708"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-007-9701-4"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10434-999-0790-0"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gassur.2006.08.018"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.sla.0000217673.04165.ea"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-011-2041-4"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11605-009-1006-4"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-008-0178-6"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-014-3841-0"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11605-014-2604-3"},{"key":"e_1_2_6_27_1","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/000313480407000205","article-title":"Personal experience with the Whipple operation: Outcomes and lessons learned","volume":"70","author":"Hoshal V","year":"2004","journal-title":"The American Surgeon"},{"key":"e_1_2_6_28_1","unstructured":"Retrospective review of 140 cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS plus HIPEC) interventions with emphasis on delayed major complications that occur after hospital discharge and prior to 90 days."}],"container-title":["Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjso.23834","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jso.23834","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T05:24:23Z","timestamp":1696397063000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jso.23834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,31]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["10.1002\/jso.23834"],"URL":"https:\/\/doi.org\/10.1002\/jso.23834","archive":["Portico"],"relation":{},"ISSN":["0022-4790","1096-9098"],"issn-type":[{"value":"0022-4790","type":"print"},{"value":"1096-9098","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,31]]}}}